Aardvark Therapeutics

Update in progress

AARD (NasdaqGS)

Aardvark Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on creating small-molecule medicines that activate innate homeostatic pathways to treat metabolic diseases. Founded in 2017, the company is headquartered in San Diego, California, and pursues therapies designed to restore the body's natural balance by modulating core metabolic processes.